Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Sodium Lactate Infusion in Patients With Glucose Transporter 1 Deficiency Syndrome (GLUT1DS)

NCT04112862 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04112862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04112862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Sodium Lactate Infusion in Patients With Glucose Transporter 1 Deficiency Syndrome (GLUT1DS)
Lead sponsor
Radboud University Medical Center
Phase
Phase 1
Overall status
Completed
Start date
May 20, 2022
Completion date
November 18, 2022
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, glut1 deficiency syndrome, glut1ds1, glut1ds2, ketogenic dieting, lactic acid blood increased